Lefrançois C, Derlon A, Le Querrec A, Lochu T, Sillard B, Deshayes J P, Delassus P, Bricard H
Département d'Anesthésie, CHU Côte-de-Nacre, Caen.
Ann Fr Anesth Reanim. 1990;9(6):485-94. doi: 10.1016/s0750-7658(05)80220-5.
The families of eight unrelated patients were studied with regard to a hereditary deficiency in antithrombin III (ATIII), protein C, or protein S. These deficiencies were recognized in the course of investigations for deep-vein thrombosis (DVT) in the eight patients. A group of 31 individuals (patients and family members), mostly less than 40-year-old was explored. Two cases of AT III deficiency were discovered, as well as 21 of protein C deficiency, and seven of protein S. Ten of the 30 have had recurrent venous thrombosis at the time of bedrest, trauma, surgery, pregnancy, postpartum or during oral contraceptive treatment. Spontaneous DVT occurred in three cases. Seventeen patients had remained asymptomatic till then. Such patients need antithrombotic treatment during surgery or pregnancy. Prophylactic treatment with enoxaparin in one patient (deficiency in protein C) during her second pregnancy is discussed. It seems that low molecular weight heparin may be a safe alternative to unfractionated heparin. Oral anticoagulants are efficient in preventing reoccurring venous thromboembolism in patients with AT III deficiency. The questions of whether oral anticoagulants should be continued in the long-term in patients with protein C or protein S deficiency who have had a DVT, and whether asymptomatic deficient patients should be given any antithrombotic treatment outside circumstances likely to induce a DVT, remain as yet unanswered.
对8名无亲缘关系患者的家族进行了抗凝血酶III(ATIII)、蛋白C或蛋白S遗传性缺乏症的研究。这些缺乏症是在对这8名患者进行深静脉血栓形成(DVT)调查过程中发现的。对一组31名个体(患者及其家庭成员)进行了探究,他们大多年龄小于40岁。发现了2例ATIII缺乏症病例、21例蛋白C缺乏症病例和7例蛋白S缺乏症病例。30名患者中有10名在卧床休息、外伤、手术、妊娠、产后或口服避孕药治疗期间出现复发性静脉血栓形成。3例发生自发性DVT。17名患者在此之前一直无症状。此类患者在手术或妊娠期间需要进行抗血栓治疗。讨论了1例蛋白C缺乏症患者在其第二次妊娠期间使用依诺肝素进行预防性治疗的情况。低分子量肝素似乎可能是普通肝素的一种安全替代药物。口服抗凝剂在预防ATIII缺乏症患者复发性静脉血栓栓塞方面有效。对于发生过DVT的蛋白C或蛋白S缺乏症患者是否应长期持续使用口服抗凝剂,以及无症状的缺乏症患者在可能诱发DVT的情况之外是否应接受任何抗血栓治疗的问题,仍未得到解答。